tradingkey.logo

Nuwellis Inc

NUWE
View Detailed Chart
3.850USD
+0.080+2.12%
Close 02/02, 16:00ETQuotes delayed by 15 min
5.26MMarket Cap
0.02P/E TTM

Nuwellis Inc

3.850
+0.080+2.12%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.12%

5 Days

+79.07%

1 Month

+112.71%

6 Months

-57.69%

Year to Date

+121.26%

1 Year

-92.55%

View Detailed Chart

TradingKey Stock Score of Nuwellis Inc

Currency: USD Updated: 2026-02-02

Key Insights

Nuwellis Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 126 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 11.00.In the medium term, the stock price is expected to trend up.Despite a strong stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current strong trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Nuwellis Inc's Score

Industry at a Glance

Industry Ranking
126 / 206
Overall Ranking
351 / 4529
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Nuwellis Inc Highlights

StrengthsRisks
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Growing
The company is in a growing phase, with the latest annual income totaling USD 8.74M.
Overvalued
The company’s latest PE is 0.02, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 134.31K shares, increasing 40.58% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 31.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.99.

Analyst Rating

Based on 1 analysts
Hold
Current Rating
11.000
Target Price
+4890.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Nuwellis Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Nuwellis Inc Info

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Ticker SymbolNUWE
CompanyNuwellis Inc
CEOErb (John L)
Websitehttps://www.nuwellis.com/
KeyAI